About This Study
The purpose of this study is to find out how well the study drug RINVOQ works for treating adults with systemic lupus erythematosus. We also want to find out how safe the study drug is for patients. RINVOQ is an FDA approved medication for other conditions.
Need volunteers diagnosed with systemic lupus erythematosus for at least 24 weeks. Taking part in this study will last approximately 58 weeks. Taking part will last a little over 2 years if you participate in both parts of the program. Study team will discuss study details with you.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- Review of Medical History
- Physical Examinations
- Study Visits and Consultations
- Surveys/Questionnaires
- Laboratory and Imaging Tests
- Specimen Sample Collection
Age & Gender
- 18 - 63 years old
- All Genders
Language
- This study enrolls English and Spanish speakers
Additional Study Information
- No compensation provided
- Reimbursement offered
Study Locations
- Greater Winston-Salem, NC